Tuberculosis is a severe infectious disease that affects the lungs and other parts of the body including the abdomen, glands, bones and the nervous system. There are three types of tuberculosis: active tuberculosis in which bacteria are rapidly multiplied and invade different organs of the body, miliary tuberculosis is a rare form of active disease that occurs when tuberculosis bacteria enter into the bloodstream, and latent tuberculosis in this person doesn’t exhibit symptoms.
Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies
and Key Companies:https://www.globalinsightservices.com/request-sample/GIS31223
As per Global Insight services’ assessment, about 20+ prominent pharma and biotech giants are
working on 20+ drugs in the Progressive Supranuclear Palsy – pipeline landscape globally.
Progressive Supranuclear Palsy Pipeline Insight, 2023" report by Global Insight Services
provides a comprehensive analysis of the ongoing clinical development activities and growth
prospect.
TB is caused by mycobacterium tuberculosis. It spreads from one person to other through air when people with active TB have cough, spit, speak or sneeze. Active TB is more predominant among people with HIV/AIDS and smokers.
The general symptoms of tuberculosis disease include sickness, weight loss, fever, night sweats, and cough for three or more weeks. In severe condition, cough with blood or mucus are exhibited.
Initial diagnosis of TB is based on the signs of the lung disease or symptoms lasting longer than two weeks. Identifying M. tuberculosis in clinical samples including sputum, pus and tissue biopsy is a part of definitive diagnosis. Chest X-ray and CT scans are imaging evaluations. The Mantoux tuberculin skin test is often used to screen people at high risk.
Get Customized report as per your requirements –https://www.globalinsightservices.com/request-customization/GIS31223
Report Highlights
Global Insight Service’s, Tuberculosis – Drug Pipeline Landscape, 2023 report provides an overview of the Tuberculosis pipeline drugs. This report covers detailed insights on Tuberculosis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Tuberculosis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
For In-Depth Competitive Analysis, Purchase this Report –https://www.globalinsightservices.com/checkout/single_user/GIS31223
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development
Like –
– Late-stage products (Phase III)
– Mid-stage products (Phase II)
– Early-stage product (Phase I)
– Pre-clinical and Discovery stage candidates
– Discontinued & Inactive candidates
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700